Integrated Filing — IndAS



General information about company

Scrip Code 532923
NSE Symbol RGL
MSEI Symbol NOTLISTED
ISIN INE722H01024
Name of company Renaissance Global Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 13-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 07-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Jewellery manufacturing
Start date and time of board meeting 13-11-2025   17:01:00
End date and time of board meeting 13-11-2025   19:57:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 54,636.31 1,07,668.16
Other income 249.80 710.63
Total income 54,886.11 1,08,378.79
2 Expenses
(a) Cost of materials consumed 15,093.84 30,734.41
(b) Purchases of stock-in-trade 31,445.16 47,941.12
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (8,191.86) (2,593.38)
(d) Employee benefit expense 2,479.37 5,336.51
(e) Finance costs 1,136.16 2,255.22
(f) Depreciation, depletion and amortisation expense 807.46 1,640.12
(f) Other Expenses
1 Foreign Exchange (Gain) /Loss (net) 1,110.83 1,353.08
2 Other Expenditure 8,635.64 17,211.94
Total other expenses 9,746.47 18,565.02
Total expenses 52,516.60 1,03,879.02
3 Total profit before exceptional items and tax 2,369.51 4,499.77
4 Exceptional items 0.00 (1,197.40)
5 Total profit before tax 2,369.51 3,302.37
6 Tax expense
7 Current tax 293.94 517.38
8 Deferred tax 52.24 101.99
9 Total tax expenses 346.18 619.37
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 2,023.33 2,683.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 2,023.33 2,683.00
17 Other comprehensive income net of taxes 1,292.25 2,657.70
18 Total Comprehensive Income for the period 3,315.58 5,340.70
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 1,927.97 2,565.96
Total profit or loss, attributable to non-controlling interests 95.36 117.04
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 3,220.22 5,223.66
Total comprehensive income for the period attributable to owners of parent non-controlling interests 95.36 117.04
21 Details of equity share capital
Paid-up equity share capital 2,145.76 2,145.76
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.8 2.39
Diluted earnings (loss) per share from continuing operations 1.8 2.39
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.8 2.39
Diluted earnings (loss) per share from continuing and discontinued operations 1.8 2.39
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes: 1. The above unaudited consolidated financial results have been prepared in accordance with applicable Indian Accounting Standard as prescribed under Section 133 of the Companies Act,2013, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. 2. The limited review as required under regulation 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 has been carried out by the statutory auditor of the Company. 3. The above unaudited financial Consolidated Results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on November 13, 2025. 4. The Group is engaged primarily in the business of 'Jewellery' and hence there is no separate reportable segment within the criteria defined under Indian Accounting Standard (Ind AS) -108 'Operating Segments'. 5. During the half year ended September 30, 2025, the Company has closed its manufacturing unit at the Bhavnagar, Gujarat w.e.f. April 15, 2025 . The expenses towards the closure of the unit aggregating to 1,197.40 Lakhs has been disclosed as an exceptional items. 6. Out of the Employee Stock Options (ESOP) outstanding as on April 01, 2025, during the half year ended September 30, 2025: a) 3,94,562 options are got cancelled pursuant to the resignation of the eligible employee of its subsidiary company i.e. Renaissance FMI Inc. USA. b) 51,000 options are granted to the eligible employees. c) 57,500 options has been exercised by the eligible employees of the Company pursuant to the RGL ESOP scheme 2021 and same are allotted to them. As on September 30, 2025, 11,31,500 options are outstanding which are granted to the eligible employees but pending to exercise and 11,11,500 options are available with the Company for new grant. 7. The figures for the previous quarters / year have been re-group/reclassified wherever necessary.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 19,662.94
Capital work-in-progress 20.73
Investment property 0.00
Goodwill 10,060.46
Other intangible assets 408.10
Intangible assets under development 20.21
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 390.42
Trade receivables, non-current 0.00
Loans, non-current 138.97
Other non-current financial assets 1,529.33
Total non-current financial assets 2,058.72
Deferred tax assets (net) 3,800.09
Other non-current assets 154.21
Total non-current assets 36,185.46
2 Current assets
Inventories 1,05,035.95
Current financial asset
Current investments 12,185.23
Trade receivables, current 79,967.15
Cash and cash equivalents 4,644.68
Bank balance other than cash and cash equivalents 4,798.78
Loans, current 215.44
Other current financial assets 710.75
Total current financial assets 1,02,522.03
Current tax assets (net) 2.00
Other current assets 3,591.41
Total current assets 2,11,151.39
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,47,336.85
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 2,145.76
Other equity 1,42,306.01
Total equity attributable to owners of parent 1,44,451.77
Non controlling interest 3,372.81
Total equity 1,47,824.58
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 1,321.03
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 13,524.06
Total non-current financial liabilities 14,845.09
Provisions, non-current 30.57
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities 0.00
Total non-current liabilities 14,875.66
Current liabilities
Current financial liabilities
Borrowings, current 55,246.93
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 148.90
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 20,667.09
Total Trade payable 20,815.99
Other current financial liabilities 7,180.08
Total current financial liabilities 83,243.00
Other current liabilities 1,079.00
Provisions, current 314.61
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 84,636.61
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 99,512.27
Total equity and liabilites 2,47,336.85
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement gains (losses) on defined benefit plans 0 0
2 Equity instrument through OCI 12464000 77825000
3 Mutual fund equity instrument through OCI -31000 255000
4 Income tax effect on above -2673000 -7492000
Total Amount of items that will not be reclassified to profit and loss 97.60 705.88
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
1 Fair Value Changes on derivatives designated on cash flow hedges -134506000 -99790000
2 Exchange differences on translation of foreign operations 220119000 269857000
3 Income tax efforts on above 33852000 25115000
Total Amount of items that will be reclassified to profit and loss 1,194.65 1,951.82
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 1,292.25 2,657.70



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 3,302.37
Adjustments for reconcile profit (loss)
Adjustments for finance costs 2,255.22
Adjustments for decrease (increase) in inventories (8,869.75)
Adjustments for decrease (increase) in trade receivables, current (9,407.77)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 2,117.51
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 1,640.12
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 31.22
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 2,035.79
Adjustments for dividend income 36.98
Adjustments for interest income 179.77
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (1.19)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (10,415.60)
Net cash flows from (used in) operations (7,113.23)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 1,107.25
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (8,220.48)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 3,262.69
Other cash payments to acquire equity or debt instruments of other entities 4,014.47
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 309.19
Purchase of property, plant and equipment 380.45
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 36.98
Interest received 113.52
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 1,339.10
Net cash flows from (used in) investing activities 666.56
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 3,997.13
Repayments of borrowings 0.00
Payments of lease liabilities 448.28
Dividends paid 0.00
Interest paid 1,926.37
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 63.26
Net cash flows from (used in) financing activities 1,685.74
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (5,868.18)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (5,868.18)
Cash and cash equivalents cash flow statement at beginning of period 10,512.86
Cash and cash equivalents cash flow statement at end of period 4,644.68